Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q92834: Variant p.Phe130Cys

X-linked retinitis pigmentosa GTPase regulator
Gene: RPGR
Feedback?
Variant information Variant position: help 130 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Phenylalanine (F) to Cysteine (C) at position 130 (F130C, p.Phe130Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In RP3; reduces interaction with PDE6D. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 130 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1020 The length of the canonical sequence.
Location on the sequence: help ATGGNNEGQLGLGDTEERNT F HVISFFTSEHKIKQLSAGSN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         ATGGNNEGQLGLGDTEERNTFHVISFFTSEHKIKQLSAGSN

                              AAGGNNEGQLGLGDTEERSTFHLISFFTSQRKIKQLSAGSN

Mouse                         AAGGNNEGQLGLGDTDDRDTFHQIVFFTPADTIKQLSAGAN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1017 X-linked retinitis pigmentosa GTPase regulator
Repeat 106 – 158 RCC1 2
Beta strand 127 – 132



Literature citations
Positional cloning of the gene for X-linked retinitis pigmentosa 3: homology with the guanine-nucleotide-exchange factor RCC1.
Roepman R.; van Duijnhoven G.; Rosenberg T.; Pinckers A.J.L.G.; Bleeker-Wagemakers L.M.; Bergen A.A.B.; Post J.; Beck A.; Reinhardt R.; Ropers H.-H.; Cremers F.; Berger W.;
Hum. Mol. Genet. 5:1035-1041(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); VARIANTS RP3 CYS-130; SER-235 AND SER-275; The retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic GMP phosphodiesterase.
Linari M.; Ueffing M.; Manson F.; Wright A.; Meitinger T.; Becker J.;
Proc. Natl. Acad. Sci. U.S.A. 96:1315-1320(1999)
Cited for: INTERACTION WITH PDE6D; CHARACTERIZATION OF RP3 VARIANTS GLN-98; CYS-130; VAL-215; SER-235; ARG-250 AND SER-275; MUTAGENESIS OF VAL-36;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.